Daiichi Sankyo Plunges on Mixed Trial Result of Lung Cancer Drug
Daiichi Sankyo Co. shares drop as much as 10.4% on Tuesday, the most since Aug. 5, after its lung cancer drug with AstraZeneca showed mixed results in a phase 3 trial. #press
https://www.bloomberg.com/news/articles/2024-09-10/daiichi-sankyo-plunges-on-mixed-trial-result-of-lung-cancer-drug?utm_source=press.coop